Donoghue Forlines’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,708
| Closed | -$721K | – | 280 |
|
|
2022
Q1 | $721K | Buy |
8,708
+2,643
| +44% | +$219K | 0.16% | 219 |
|
|
2021
Q4 | $455K | Buy |
6,065
+764
| +14% | +$57.3K | 0.08% | 242 |
|
|
2021
Q3 | $616K | Buy |
5,301
+1,118
| +27% | +$130K | 0.12% | 174 |
|
|
2021
Q2 | $928K | Sell |
4,183
-339
| -7% | -$75.2K | 0.17% | 141 |
|
|
2021
Q1 | $598K | Buy |
4,522
+275
| +6% | +$36.4K | 0.12% | 173 |
|
|
2020
Q4 | $735K | Buy |
+4,247
| New | +$735K | 0.14% | 176 |
|
|
2019
Q4 | – | Sell |
-30,856
| Closed | -$2.31M | – | 190 |
|
|
2019
Q3 | $2.31M | Buy |
+30,856
| New | +$2.31M | 0.33% | 111 |
|